S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
NASDAQ:OBLN

Obalon Therapeutics News Headlines

$3.62
+0.19 (+5.54 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.48
Now: $3.62
$3.65
50-Day Range
$1.51
MA: $4.04
$8.28
52-Week Range
$0.62
Now: $3.62
$10.77
Volume176,483 shs
Average Volume14.90 million shs
Market Capitalization$28.13 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.69

Headlines

Obalon Therapeutics (NASDAQ OBLN) News Headlines Today

Source:
SourceHeadline
Obalon Therapeutics (NASDAQ:OBLN) Trading Up 5.5%Obalon Therapeutics (NASDAQ:OBLN) Trading Up 5.5%
americanbankingnews.com - March 1 at 9:20 PM
Obalon Therapeutics (NASDAQ:OBLN) Stock Price Down 8.7%Obalon Therapeutics (NASDAQ:OBLN) Stock Price Down 8.7%
americanbankingnews.com - February 23 at 7:42 PM
Obalon Therapeutics (NASDAQ:OBLN) Raised to Buy at Alliance Global PartnersObalon Therapeutics (NASDAQ:OBLN) Raised to Buy at Alliance Global Partners
americanbankingnews.com - February 18 at 8:26 AM
Obalon Therapeutics (NASDAQ:OBLN) Stock Price Down 8.4%Obalon Therapeutics (NASDAQ:OBLN) Stock Price Down 8.4%
americanbankingnews.com - February 17 at 8:36 PM
Obalon Therapeutics (NASDAQ:OBLN)  Shares Down 9.1% Obalon Therapeutics (NASDAQ:OBLN) Shares Down 9.1%
americanbankingnews.com - February 11 at 9:42 PM
Obalon Therapeutics, Inc. (NASDAQ:OBLN) Sees Significant Growth in Short InterestObalon Therapeutics, Inc. (NASDAQ:OBLN) Sees Significant Growth in Short Interest
americanbankingnews.com - February 11 at 6:24 AM
Obalon Therapeutics (NASDAQ:OBLN) Trading Up 10.3%Obalon Therapeutics (NASDAQ:OBLN) Trading Up 10.3%
americanbankingnews.com - February 10 at 7:16 PM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates VIE, SMTX, NK, OBLN; Shareholders Are Encouraged to Contact the FirmINVESTIGATION ALERT: Halper Sadeh LLP Investigates VIE, SMTX, NK, OBLN; Shareholders Are Encouraged to Contact the Firm
finance.yahoo.com - February 2 at 2:20 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Obalon Therapeutics, Inc. - OBLNSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Obalon Therapeutics, Inc. - OBLN
finance.yahoo.com - January 23 at 9:10 AM
OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the FirmOBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm
finance.yahoo.com - January 22 at 6:28 PM
OBALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Obalon Therapeutics, Inc. - OBLNOBALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Obalon Therapeutics, Inc. - OBLN
businesswire.com - January 22 at 1:28 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc.
finance.yahoo.com - January 21 at 7:16 PM
ROCE Insights For Obalon TherapeuticsROCE Insights For Obalon Therapeutics
finance.yahoo.com - January 21 at 2:15 PM
PFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA ChiefPFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA Chief
nasdaq.com - January 21 at 2:48 AM
Obalon Surges 470% On ReShape Lifesciences Merger AgreementObalon Surges 470% On ReShape Lifesciences Merger Agreement
msn.com - January 20 at 4:48 PM
Return On Capital Employed Overview: Obalon TherapeuticsReturn On Capital Employed Overview: Obalon Therapeutics
finance.yahoo.com - December 7 at 4:42 PM
Why Is It Moving? Analyzing The Upward Movement in Obalon Therapeuticss Stock TodayWhy Is It Moving? Analyzing The Upward Movement in Obalon Therapeutics's Stock Today
finance.yahoo.com - December 7 at 4:42 PM
Stock Alert: Obalon Therapeutics Jumps 30%Stock Alert: Obalon Therapeutics Jumps 30%
nasdaq.com - December 2 at 6:06 PM
Obalon Therapeutics EPS misses by $0.13Obalon Therapeutics EPS misses by $0.13
seekingalpha.com - November 6 at 6:57 PM
Obalon Announces Third Quarter 2020 Financial ResultsObalon Announces Third Quarter 2020 Financial Results
finance.yahoo.com - November 6 at 6:57 PM
Obalon Therapeutics IncObalon Therapeutics Inc
bloomberg.com - October 30 at 6:19 PM
Obalon Therapeutics, Inc. Common Stock (OBLN)Obalon Therapeutics, Inc. Common Stock (OBLN)
nasdaq.com - October 19 at 2:17 PM
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon SystemObalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
finance.yahoo.com - August 13 at 10:07 AM
Obalon Therapeutics EPS misses by $0.24Obalon Therapeutics EPS misses by $0.24
seekingalpha.com - July 30 at 8:25 AM
Obalon Announces Second Quarter 2020 Financial ResultsObalon Announces Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 8:25 AM
Obalon Says Cash Crunch Could Push Company Into BankruptcyObalon Says Cash Crunch Could Push Company Into Bankruptcy
www.wsj.com - June 19 at 1:31 PM
Obalons retail treatment centers to remain shut; delays shipmentsObalon's retail treatment centers to remain shut; delays shipments
seekingalpha.com - June 19 at 1:31 PM
Obalon Therapeutics EPS misses by $0.17, beats on revenueObalon Therapeutics EPS misses by $0.17, beats on revenue
seekingalpha.com - June 19 at 8:31 AM
Obalon Announces First Quarter 2020 Financial Results and Business UpdateObalon Announces First Quarter 2020 Financial Results and Business Update
finance.yahoo.com - June 19 at 8:31 AM
Obalon Therapeutics Inc. Announces Closing of $16.6 Million Public OfferingObalon Therapeutics Inc. Announces Closing of $16.6 Million Public Offering
www.bloomberg.com - June 17 at 3:31 PM
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business EnvironmentObalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
finance.yahoo.com - May 11 at 4:50 PM
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as DirectorWilliam Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
finance.yahoo.com - May 8 at 5:35 PM
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric BalloonsObalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
finance.yahoo.com - April 28 at 11:10 AM
Obalon Therapeutics explores strategic alternatives as coronavirus hits | NasdaqObalon Therapeutics explores strategic alternatives as coronavirus hits | Nasdaq
www.nasdaq.com - March 26 at 9:21 PM
Obalon Engages Canaccord Genuity to Explore Financial and Strategic AlternativesObalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
finance.yahoo.com - March 25 at 12:32 PM
Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus PandemicObalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic
finance.yahoo.com - March 17 at 5:29 PM
Edited Transcript of OBLN earnings conference call or presentation 27-Feb-20 1:30pm GMTEdited Transcript of OBLN earnings conference call or presentation 27-Feb-20 1:30pm GMT
finance.yahoo.com - March 9 at 8:40 PM
Obalon Therapeutics down 13% premarket on Q4 resultsObalon Therapeutics down 13% premarket on Q4 results
seekingalpha.com - February 27 at 2:11 PM
Obalon Therapeutics EPS misses by $0.09, beats on revenueObalon Therapeutics EPS misses by $0.09, beats on revenue
seekingalpha.com - February 27 at 9:10 AM
Obalon Announces Fourth Quarter and Full Year 2019 Financial ResultsObalon Announces Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 27 at 9:10 AM
Obalon Announces Opening of Second Retail Treatment Center in Orange County, CAObalon Announces Opening of Second Retail Treatment Center in Orange County, CA
finance.yahoo.com - February 20 at 8:53 AM
Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern TimeObalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time
finance.yahoo.com - February 13 at 1:10 PM
Obalon +8.6% on new stock purchase agreementObalon +8.6% on new stock purchase agreement
seekingalpha.com - February 7 at 7:04 PM
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital FundObalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund
finance.yahoo.com - February 7 at 7:04 PM
Is OBALON THERPTCS (OBLN) Stock Outpacing Its Medical Peers This Year?Is OBALON THERPTCS (OBLN) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - January 24 at 4:48 PM
Have Insiders Been Buying Obalon Therapeutics, Inc. (NASDAQ:OBLN) Shares?Have Insiders Been Buying Obalon Therapeutics, Inc. (NASDAQ:OBLN) Shares?
finance.yahoo.com - January 13 at 5:07 PM
Obalon Enters into a Distribution Agreement for QatarObalon Enters into a Distribution Agreement for Qatar
finance.yahoo.com - December 18 at 8:50 AM
Spindletop Capital Management Promotes Kelly Huang, Ph.D. to Managing DirectorSpindletop Capital Management Promotes Kelly Huang, Ph.D. to Managing Director
finance.yahoo.com - December 10 at 5:00 PM
Obalon To Present at Two Upcoming Institutional Investor ConferencesObalon To Present at Two Upcoming Institutional Investor Conferences
finance.yahoo.com - November 14 at 1:01 PM
Edited Transcript of OBLN earnings conference call or presentation 8-Nov-19 2:00pm GMTEdited Transcript of OBLN earnings conference call or presentation 8-Nov-19 2:00pm GMT
finance.yahoo.com - November 14 at 8:00 AM
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.